Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab

PURPOSE: This study evaluated visual function and anatomic and vision-related quality-of-life outcomes in recalcitrant neovascular age-related macular degeneration (AMD) subjects switched to aflibercept (Eylea(®)) from ranibizumab (Lucentis(®)). METHODS: In a single-center study conducted in Barrie,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Donald R, Flinn, Nicholas AP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403004/
https://www.ncbi.nlm.nih.gov/pubmed/28458510
http://dx.doi.org/10.2147/OPTH.S131343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403004/
https://www.ncbi.nlm.nih.gov/pubmed/28458510
http://dx.doi.org/10.2147/OPTH.S131343

Ejemplares similares